Inadequate anticoagulant treatment for stroke prevention in atrial fibrillation

3' education - Apr. 1, 2016 - VBWG Meeting at ACC 2016, Chicago, IL, USA - Christian T. Ruff, MD - Brigham and Women's Hospital, Boston, MA, USA

Despite the availability of effective and safer novel oral anticoagulants (NOACs), as compared with vitamin K antagonists, many high risk patients with atrial fibrillation receive inadequate anticoagulation for stroke prevention. Still too much aspirin is used, which is not effective at preventing stroke.

Educational information

Vascular Biology Working Group Meeting at ACC 2016, Chicago, IL, USA

Disclosures

Christian T. Ruff, MD - Brigham and Women's Hospital, Boston, MA, USA

The information and data provided in this program were updated and correct at the time of the program development, but may be subject to change.